Tag: CORO
Third Dose of COVID-19 Vaccine Seems Safe for Young Children
No new safety concerns reported among children aged 6 months to 5 years receiving third dose of mRNA COVID-19 vaccine
COVID-19-Associated Smell, Taste Disturbance Is Declining
Odds ratios for COVID-19-associated smell or taste disturbance significantly reduced, reaching 0.070 during omicron B peak interval
Almost All Blood Donors Had SARS-CoV-2 Antibodies by Third Quarter of 2022
47.7 percent of those ≥16 years had hybrid immunity, with the lowest prevalence seen for adults aged ≥65 years
Nirmatrelvir-Ritonavir Effective for Outpatient Treatment of COVID-19
Reduces 30-day risk for hospitalization and death, while only death was reduced in association with molnupiravir
Twelve Symptoms Contribute to Postacute Sequelae of SARS-CoV-2
Symptom-based postacute sequelae of SARS-CoV-2 definition includes postexertional malaise, fatigue, brain fog, dizziness, GI symptoms
U.S. COVID-19 Hospitalizations Reach Record Low
Hospitalizations are among the few COVID-19 metrics still being monitored by public health officials
FDA Grants Full Approval to Paxlovid to Treat COVID-19
Paxlovid has been taken by seniors and others at high risk for severe COVID-19 under an emergency use approval
Low Risk of Recurrent Thrombotic Events After COVID-19-Linked VTE
Risk of recurrent thrombotic events similar to that of patients with VTE linked to hospitalization for other acute medical illness
Lung Transplants From COVID-19-Positive Donors May Be Feasible
Data from 47 carefully selected transplants show early posttransplant outcomes are similar to those seen with COVID-19-negative donors
Preexisting OSA Linked to Odds of Postacute Sequelae of SARS-CoV-2
Increased odds ratio observed for probable PASC in association with preexisting obstructive sleep apnea diagnosis
